Citigroup
PGEN icon

Citigroup’s Precigen PGEN Stock Holding History

Citigroup’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,600
Closed -$118K – 7113
2020
Q4 		$118K Hold
11,600
– – ﹤0.01% 5404
2020
Q3 		$41K Sell
11,600
-100
-0.9% -$475 ﹤0.01% 5725
2020
Q2 		$58K Sell
11,700
-8,400
-42% -$28.6K ﹤0.01% 5939
2020
Q1 		$68K Sell
20,100
-16,400
-45% -$70.8K ﹤0.01% 5687
2019
Q4 		$200K Sell
36,500
-200
-0.5% -$1.13K ﹤0.01% 5173
2019
Q3 		$210K Buy
36,700
+4,000
+12% +$27.2K ﹤0.01% 5114
2019
Q2 		$250K Sell
32,700
-40,800
-56% -$220K ﹤0.01% 5070
2019
Q1 		$387K Buy
73,500
+50,700
+222% +$351K ﹤0.01% 4455
2018
Q4 		$149K Buy
22,800
+2,800
+14% +$31.4K ﹤0.01% 5302
2018
Q3 		$344K Sell
20,000
-3,100
-13% -$46.1K ﹤0.01% 4694
2018
Q2 		$322K Buy
23,100
+1,500
+7% +$25.3K ﹤0.01% 4555
2018
Q1 		$331K Sell
21,600
-6,900
-24% -$98.7K ﹤0.01% 4430
2017
Q4 		$328K Buy
28,500
+300
+1% +$4.47K ﹤0.01% 4546
2017
Q3 		$536K Buy
28,200
+6,900
+32% +$142K ﹤0.01% 4052
2017
Q2 		$513K Sell
21,300
-8,200
-28% -$180K ﹤0.01% 3964
2017
Q1 		$585K Sell
29,500
-19,235
-39% -$429K ﹤0.01% 3733
2016
Q4 		$1.17M Buy
48,735
+13,723
+39% +$382K ﹤0.01% 3511
2016
Q3 		$972K Sell
35,012
-4,339
-11% -$115K ﹤0.01% 3253
2016
Q2 		$960K Buy
39,351
+6,659
+20% +$189K ﹤0.01% 3009
2016
Q1 		$1.1M Buy
32,692
+5,247
+19% +$165K ﹤0.01% 3227
2015
Q4 		$820K Buy
27,445
+9,989
+57% +$337K ﹤0.01% 3359
2015
Q3 		$550K Buy
17,456
+8,577
+97% +$419K ﹤0.01% 3657
2015
Q2 		$429K Buy
8,879
+8,670
+4,148% +$365K ﹤0.01% 3838
2015
Q1 		$9K Buy
+209
New +$7.51K ﹤0.01% 6507

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup's PGEN Position: Q2 2026 in Review

Citigroup increased its Precigen (PGEN) stake by 90% in Q2 2026, buying an estimated $1.48M and bringing the position to 724,887 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2312.

Citigroup first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Citigroup held 724,887 shares of Precigen worth $4.13M as of Q2 2026.
  • Citigroup bought 343,522 Precigen shares in Q2 2026, an estimated $1.48M.
  • Precigen made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2312 holding.
  • Citigroup first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.